Rheumatology | Oxford Academic The official journal of the British Society for Rheumatology Publishes high-quality scientific (basic and translational) and clinical-epidemiological papers on a wide range of paediatric and adult rheumatological and musculoskeletal conditions
Biologic and targeted synthetic DMARD safety in inflammatory arthritis . . . Abstract This guideline will provide up-to-date and evidence-based recommendations for the safe use of biologic and targeted synthetic DMARDs in individuals with inflammatory arthritis (IA) across the life course Important updates from the 2019 iteration of this guideline will include the incorporation of newer pharmacotherapies (such as Janus kinase inhibitors) and an extension of the target
Volume 9 Issue Supplement_1 - Oxford Academic An official journal of the British Society for Rheumatology Rheumatology Advances in Practice, a fully open access journal, provides a global forum for the publication ofà  à  à  à  clinical papers on all areas of rheumatology and musculoskeletal practice